On June 22, a new European law (Regulation (EU) 2022/860) came into effect, stipulating that dietary supplements containing red yeast rice must contain less than 3 mg of monacolin per daily dose.
To comply with this new regulation, we have reformulated the product, which now contains, per tablet:
- 2.9 mg of Monacolin K: Monacolins are obtained from the fermentation of rice with the red yeast Monascus Purpureus. It has been used in China and other Asian countries for centuries as traditional medicine.
- 10 mg of Coenzyme Q10: To counteract the interference of monacolins with the levels of CoQ10 in the body.
- 4 mg of Vitamin B3.
To compensate for this decrease in doses, we have tripled the number of tablets per package, which is now 540 instead of 180.
Our Red Yeast Rice tablets have been analyzed by an accredited laboratory. We conduct periodic analyses in accredited independent laboratories to ensure the highest quality of the product.